ANAPC10
Anaphase-promoting complex subunit 10
Also known as: APC10, APC10_HUMAN, DKFZP564L0562, DOC1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UM13
- Gene
- ANAPC10
- Ensembl
- ENSG00000164162
- Chromosome
- 4
- Canonical length
- 185 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
ANAPC10 is a core subunit of the anaphase-promoting complex (APC), or cyclosome, a ubiquitin protein ligase that is essential for progression through the cell cycle. APC initiates sister chromatid separation by ubiquitinating the anaphase inhibitor securin (PTTG1; MIM 604147) and triggers exit from mitosis by ubiquitinating cyclin B (CCNB1; MIM 123836), the activating subunit of cyclin-dependent kinase-1 (CDK1; MIM 116940) (summary by Wendt et al., 2001 [PubMed 11524682]).[supplied by OMIM, Feb 2011]
Canonical amino-acid sequenceUniProt
185 residues, UniProt reviewed canonical sequence.
>Q9UM13|ANAPC10
1 MTTPNKTPPG ADPKQLERTG TVREIGSQAV WSLSSCKPGF GVDQLRDDNL ETYWQSDGSQ
61 PHLVNIQFRR KTTVKTLCIY ADYKSDESYT PSKISVRVGN NFHNLQEIRQ LELVEPSGWI
121 HVPLTDNHKK PTRTFMIQIA VLANHQNGRD THMRQIKIYT PVEESSIGKF PRCTTIDFMM
181 YRSIRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANAPC10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- testis: 18 nTPM
- skeletal muscle: 14 nTPM
- tongue: 14 nTPM
- breast: 13 nTPM
- heart muscle: 13 nTPM
- thymus: 13 nTPM
Single-cell type
- distal convoluted tubule cells: 106 nCPM
- podocytes: 88 nCPM
- renal connecting tubule cells: 79 nCPM
- renal collecting duct intercalated cells: 79 nCPM
- proximal tubule cells: 74 nCPM
- loop of henle epithelial cells: 69 nCPM
Immune cell
- basophil: 26 nTPM
- T-reg: 18 nTPM
- NK-cell: 17 nTPM
- plasmacytoid DC: 16 nTPM
- memory B-cell: 15 nTPM
- naive CD8 T-cell: 14 nTPM
Brain region
- cerebellum: 9.5 nTPM
- white matter: 8.2 nTPM
- midbrain: 8.1 nTPM
- spinal cord: 7.5 nTPM
- hypothalamus: 7.4 nTPM
- medulla oblongata: 6.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.84
- DepMap mean gene effect
- -1.65
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anaphase-promoting complex-dependent catabolic process
- cell division
- protein branched polyubiquitination
- protein K11-linked ubiquitination
- protein K48-linked ubiquitination
- regulation of meiotic cell cycle
- regulation of mitotic cell cycle
Cellular components
Protein domainsUniProt · Pfam · InterPro
- APC10/DOC domain
- Galactose-binding-like domain superfamily
- Anaphase-promoting complex, subunit 10 (APC10)
- Anaphase-promoting complex subunit APC10/Doc1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ANAPC10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANAPC10 as an antibody target. Whether an autoantibody or antibody against ANAPC10 could matter depends on whether native ANAPC10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANAPC10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ANAPC10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...